Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Loading…
Phase II Biologic Effects Trial of Recombinant Interleukin-11 (rhIL-11, Neumega) in Moderate or Mild Hemophilia A or Von Willebrand Disease Unable to Use DDAVP
Ragni, Margaret V., Novelli, Enrico M., Murshed, Anila, Merricks, Elizabeth P., Kloos, Mark T., Nichols, Timothy C.
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
Loading…
A phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand disease
RAGNI, M. V., JANKOWITZ, R. C., CHAPMAN, H. L., MERRICKS, E. P., KLOOS, M. T., DILLOW, A. M., NICHOLS, T. C.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.09.2008)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.09.2008)
Get full text
Journal Article
Loading…
Recombinant Interleukin-11 (rhIL-11) in Women with Refractory Menorrhagia and Von Willebrand Disease
Jankowitz, Rachel C., Ragni, Margaret V., Chapman, Holly L., Merricks, Elizabeth P., Kloos, Mark T., Dillow, Aaron M., Franck, Helen, Nichols, Timothy C.
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article